GloMax(R) Discover System and Dual Injectors with Pumps NOI-CC-OLAO-26-007847
Summary
AI-generated · Jul 09, 2026Sole-source award to Promega Corporation for the GloMax Discover System and Dual Injectors with Pumps to support NIH Clinical Center research investigations central to its mission. Failure to fulfill could jeopardize time-sensitive experiments and waste already invested funds; the sole-source justification is based on 41 U.S.C. 253(c)(1) as implemented by FAR 6.302-1.
This is not a request for proposals. Other suppliers may submit capability statements for consideration, but responses must be received by the closing date and should reference NOI-CC-OLAO-26-007847.
This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Promega Corporation. Acquisition Description: Order is associated with research investigations that are central to the mission of the Clinical Center and the NIH. Failure to fulfill would jeopardize time-sensitive experiments & would waste already-invested funds. The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-CC-OLAO-26-007847) by 12:00 PM eastern standard time on 07/23/2026 to: valerie.gregorio@nih.gov. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
From Special Notice posted on Jul 08, 2026Notice history
1Details
Award Information
Not yet awarded
Agency
Place of Performance
USA